Abstract
Protein oxidation is a post-translational modification that can have beneficial or detrimental effects on cells. The interaction of reactive oxygen species (ROS) with proteins leads to their oxidation and ROS may be produced by several different enzymes. The first section of this review examines the major intracellular sources of ROS, with special attention paid to mitochondria and NADPH oxidases. It discusses the different oxidation of amino acid residues with a focus on cysteine oxidation as it is involved in many signaling pathways. Carbonylation and nitrosylation are two other protein modifications that are of particular importance in cellular metabolism. The final section is concerned with the role that protein oxidation plays in disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AD:
-
Alzheimer’s disease
- CF:
-
Cystic fibrosis
- COX:
-
Cyclooxygenase
- DUOX:
-
Dual oxidase
- HO• :
-
Hydroxyl radical
- H2O2 :
-
Hydrogen peroxide
- LOX:
-
Lipoxygenase
- MPO:
-
Myeloperoxidase
- NO• :
-
Nitric oxide
- NOS:
-
Nitric oxide synthase
- Nox:
-
NADPH Oxidase
- O •−2 :
-
Superoxide
- PD:
-
Parkinson’s disease
- RNS:
-
Reactive nitrogen species
- ROS:
-
Reactive oxygen species
- SOD:
-
Superoxide dismutase
- Trx2:
-
Thioredoxin2
- XDH:
-
Xanthine dehydrogenase
- XO:
-
Xanthine oxidase
- XOR:
-
Xanthine oxidoreductase
References
Aksenov, M.Y., Aksenova, M.V., Butterfield, D.A., et al. (2001). Protein oxidation in the brain in Alzheimer’s disease. Neuroscience 103:373–383.
Alam, Z.I., Daniel, S.E., Lees, A.J., et al. (1997). Generalised increase in protein carbonyls in the brain in Parkinson’s but not incidental Lewy body disease. J. Neurochem. 69:1326–1329.
Babbs, C.F. (1992). Oxygen radicals in ulcerative colitis. Free Radical Biol. Med. 13:169-181.
Banfi, B., Molnar, G., Maturana, A., et al. (2001). A Ca2+-activated NADPH oxidase in testis, spleen, and lymph nodes. J. Biol. Chem. 276:37594–37601.
Banfi, B., Malgrange, B., Knisz, J., et al. (2004). NOX3, a superoxide-generating NADPH oxidase of the inner ear. J. Biol. Chem. 279:46065–46072.
Banfi, B., Tirone, F., Durussel, I., et al. (2004). Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5). J. Biol. Chem. 279:18583–18591.
Barja, G., and Herrero, A. (1998). Localization at complex I and mechanism of the higher free radical production of brain nonsynaptic mitochondria in the short-lived rat than in the longevous pigeon. J. Bioenerg. Biomembr. 30:235–243.
Barrett, W.C., DeGnore, J.P., Konig, S., et al. (1999). Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38:6699–6705.
Bedard, K., and Krause, K.H. (2007). The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol. Rev. 87:245–313.
Boscia, F., Grattagliano, I., Vendemiale G., et al. (2000). Protein oxidation and lens opacity in humans. Invest. Ophthalmol. Vis. Sci. 41:2461–2465.
Boueiz, A., Damarla, M., and Hassoun, P.M. (2008). Xanthine oxidoreductase in respiratory and cardiovascular disorders. Am. J. Physiol. Lung Cell. Mol. Physiol. 294:L830–L840.
Brennan, M.L., and Hazen, S.L. (2005). Amino acid and protein oxidation in cardiovascular disease. Amino Acids 25:365–374.
Butler, J., Jayson, G.G., and Swallow, A.J. (1975). Reaction between superoxide anion radical and cytochrome C. Biochim. Biophys. Acta 408:215–222.
Butterfield, D.A., and Stadtman, E.R. (1997). Protein oxidation processes in aging brain. Adv. Cell Aging Gerontol. 2:161–191.
Cakatay, U. (2005). Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab. 31:551–557.
Carney, J. M., Starke-Reed, P. E., Oliver, C. N., et al. (1991) Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity loss and loss of temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. Proc. Natl. Acad. Sci. U.S.A. 88:3633–3636.
Caselli, A., Marzocchini, R., Camici, G., et al. (1998). The inactivation mechanism of low molecular weight phosphotyrosine-protein phosphatase by H2O2. J. Biol. Chem. 273:32554–32560.
Chakravarti, B., and Chakravarti, D.N. (2007). Oxidative modification of proteins: age-related changes. Gerontology 53:128–139.
Chen, Y., Cai, J.Y., Murphy, T.J., et al. (2002). Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J. Biol. Chem. 277:33242–33248.
Cheng, G.J., Cao, Z.H., Xu, X.X., et al. (2001). Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269:131–140.
Chiarugi, P., Fiaschi, T., Taddei, M.L., et al. (2001). Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J. Biol. Chem. 276:33478–33487.
Choi, J., Sullards, M.C., Olzmann, J.A., et al. (2006). Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J. Biol. Chem. 281:10816–10824.
Chung, H.Y., Baek, B.S., Song, S.H., et al. (1997). Xanthine dehydrogenase, xanthine oxidase and oxidative stress. Age 20:127–140.
Dalle-Donne, I., Giustarini, D., Colombo, R., et al. (2003). Protein carbonylation in human diseases. Trends Mol. Med. 9:169–176.
Dalle-Donne, I., Aldini, G., Carini, M., et al. (2006). Protein carbonylation, cellular dysfunction, and disease progression. J. Cell. Mol. Med. 10:389–406.
Danielson, S.R., and Andersen, J.K. (2008). Oxidative and nitrative protein modifications in Parkinson’s disease. Free Radical Biol. Med. 44:1787–1794.
Davies, M.J., and Truscott, R.J. (2001). Photo-oxidation of proteins and its role in cataractogenesis. J. Photochem. Photobiol. B 63:114–125.
Davis, P.B.O. Pathophysiology of the lung disease in cystic fibrosis. In: Davis P.B., ed. Cystic fibrosis. New York: Marcel Dekker, 1993, pp. 193–218.
Denu, J.M., and Dixon, J.E. (1998). Protein tyrosine phosphatases: mechanisms of catalysis and regulation. Curr. Opin. Chem. Biol. 2:633–641.
Donko, A., Peterfi, Z., Sum, A., et al. (2005). Dual oxidases. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 360:2301–2308.
Dupuy, C., Ohayon, R., Valent, A., et al. (1999). Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cDNAs. J. Biol. Chem. 274:37265–37269.
Edderkaoui, M., Hong, P., Vaquero, E.C., et al. (2005). Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase. Am. J. Physiol. Gastrointest. Liver Physiol. 289:G1137–G1147.
Edens, W.A., Sharling, L., Cheng, G.J., et al. (2001). Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91 phox. J. Cell Biol. 154:879–891.
Esteves, A.R., ArduÃno, D.M., Swerdlow, R.H., et al. (2009). Oxidative stress involvement in α-synuclein oligomerization in Parkinson disease cybrids. Antioxid. Redox Signal 11:439–448.
Farrer, M.J. (2006). Genetics of Parkinson disease: paradigm shifts and future prospects. Nat. Rev. Genet. 7:306–318.
Fetrow, J.S., Siew, N., Skolnick, J. (1999). Structure-based functional motif identifies a potential disulfide oxidoreductase active site in the serine/threonine protein phosphatase-1 subfamily. FASEB J. 13:1866–1874.
Fleury, C., Mignotte, B., and Vayssiere, J.L. (2002). Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84:131–141.
Forster, M. J., Dubey, A., Dawson, K. M., et al. (1996). Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc. Natl. Acad. Sci. U.S.A. 93:4765–4769.
Gao, T., Furnari, F., and Newton, A.C. (2005). PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell 18:13–24.
Geiszt, M., Kopp, J.B., Varnai, P., et al. (2000). Identification of renox, an NAD(P)H oxidase in kidney. Proc. Natl. Acad. Sci. U.S.A. 97:8010–8014.
Geiszt, M., Witta, J., Baffi, J., et al. (2003). Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J. 17:1502–1504.
Go, Y.M., and Jones, D.P. (2008). Redox compartmentalization in eukaryotic cells. Biochim. Biophys. Acta 1780:1271–1290.
Goedert, M., and Spillantini, M.G. (2006). A century of Alzheimer’s disease. Science 314:777–781.
Guidot, D.M., Repine, J.E., Kitlowski, A.D., et al. (1995). Mitochondrial respiration scavenges extramitochondrial superoxide anion via a nonenzymatic mechanism. J. Clin. Invest. 96:1131–1136.
Guy, G.R., Philp, R., and Tan, Y.H. (1995). Activation of protein kinases and the inactivation of protein phosphatase 2A in tumour necrosis factor and interleukin-1 signal-transduction pathways. Eur. J. Biochem. 229:503–511.
Halliwell, B., and Gutteridge, J. (1999). Free radicals in biology and medicine, 3rd ed. Oxford: Oxford University Press.
Hampton, M.B., and Orrenius, S. (1997). Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett. 414:552–556.
Hennekam, R.C. (2006). Hutchinson-Gilford progeria syndrome: review of the phenotype. Am. J. Med. Genet. A, 140:2603–2624.
Hensley, K., Robinson, K.A., Gabbita, S.P., et al. (2000). Reactive oxygen species, cell signaling, and cell injury. Free Radical Biol. Med. 28:1456–1462.
Hitchon, C.A., and El-Gabalawy, H.S. (2004).Oxidation in rheumatoid arthritis. Arthritis Res. Ther. 6:265–278.
Hunter, T. (1995) Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signalling. Cell 80:225–236.
Inanami, O., Johnson, J.L., McAdara, J.K., et al. (1998). Activation of the leukocyte NADPH oxidase by phorbol ester requires the phosphorylation of p47(PHOX) on serine 303 or 304.J. Biol. Chem. 273:9539–9543.
Iyer, G.Y., Islam, M.F., and Quastel, J.H. (1961). Biochemical aspects of phagocytosis. Nature 192:535–542.
Jung T., and Grune T.T. (2008). The proteasome and its role in the degeneration of oxidised proteins. IUBMB Life 60:743–752.
Kakkar, P., and Singh, B.K. (2007). Mitochondria: a hub of redox activities and cellular distress control. Mol. Cell. Biochem. 305:235–253.
Kamata, H., Manabe, T., Oka, S., et al. (2002). Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops. FEBS Lett. 519:231–237.
Kawahara, T., Ritsick, D., Cheng, G.J., et al. (2005). Point mutations in the proline-rich region of p22(phox) are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation. J. Biol. Chem. 280:31859–31869.
Kieran, M.W., Gordon, L., and Kleinman, M. (2007). New approaches to Progeria. Pediatrics 120:834–841.
Kim, C., Kim, J.Y., and Kim, J.H. (2008). Cytosolic phospholipase A(2), lipoxygenase metabolites, and reactive oxygen species. BMB Rep. 41:555–559.
Klebanoff, S.J. (2005). Myeloperoxidase: friend and foe. J. Leukoc. Biol. 77:598–625.
Klumpp, S., Selke, D., and Krieglstein, J. (2003). Protein phosphatase type 2C dephosphorylates BAD. Neurochem. Int. 42:555–560.
Kubisch, H. M., Wang, J., Luche, R., et al. (1994). Transgenetic copper/zinc superoxide dismutase modulates susceptibility to type 1 diabetes. Proc. Natl. Acad. Sci. U.S.A. 91:9956–9959.
Kuhn, H., and Thiele, B.J. (1999). The diversity of the lipoxygenase family: Many sequence data but little information on biological significance. FEBS Lett. 449:7–11.
Lamb, N.J., Gutteridge, J.M., Baker, C., et al. (1999). Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: Evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Critical Care Med. 27:1738–1744.
Lambeth, J.D., Kawahara, T., and Diebold, B. (2007). Regulation of Nox and Duox enzymatic activity and expression. Free Radical Biol. Med. 43:319–331.
Lee, S.R., Kwon, K.S., Kim, S.R., et al. (1998). Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J. Biol. Chem. 273:15366–15372.
Leseney, A.M., Deme, D., Legue, O., et al. (1999). Biochemical characterization of a Ca2+/NAD(P)H-dependent H2O2 generator in human thyroid tissue. Biochimie 81:373–380.
Levine, R.L., Mosoni, L., Berlett, B.S., et al. (1996). Methionine residues as endogenous antioxidants in proteins. Proc. Natl. Acad. Sci. U.S.A. 93:15036–15040.
Mackey, A.M., Sanvicens, N., Groeger, G., et al. (2008). Redox survival signalling in retina-derived 661W cells. Cell Death Differ. 15:1291–1303.
Mahadev, K., Zilbering, A., Zhu, L., et al. (2001). Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1B in vivo and enhances the early insulin action cascade. J. Biol. Chem. 276:21938–21942.
Mahadev, K., Motoshima, H., Wu, X.D., et al. (2004). The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol. Cell. Biol. 24:1844–1854.
Malle, E., Furtmuller, P.G., Sattler, W., et al. (2007). Myeloperoxidase: a target for new drug development? Br. J. Pharmacol. 152:838–854.
Mancuso, M., Coppede, F., Migliore, L., et al. (2006). Mitochondrial dysfunction, oxidative stress and neurodegeneration. J. Alzheimer’s Dis. 10:59–73.
Markesbery, W.R., and Carney, J.M. (1999). Oxidative alterations in Alzheimer’s disease. Brain Pathol. 9:133–146.
Markesbery, W.R., and Lovell, M.A. (2007). Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch. Neurol. 64:954–956.
Meng, T.C., Fukada, T., and Tonks, N.K. (2002). Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9:387–399.
Millward, T.A., Zolnierowicz, S., and Hemmings, B.A. (1999). Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 24:186–191.
Miyasaki, K.T., Song, J.P., and Murthy, A.R.K. (1991). Secretion of myeloperoxidase isoforms by human neutrophils. Anal. Biochem. 193:38–44.
Moncada, S., and Erusalimsky, J.D. (2002). Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat. Rev. Mol. Cell Biol. 3:214–220.
Murphy, M.E., and Kehrer, J.P. (1989). Oxidative stress and muscular dystrophy. Chem. Biol. Interact. 69:101–173.
Nawata, R., Yujiri, T., Nakamura, Y., et al. (2003). MEK kinase 1 mediates the antiapoptotic effect of the Bcr-Abl oncogene through NF-kappaB activation. Oncogene 22:7774–7780.
Nishino, T., Okamoto, K., Eger, B.T., et al. (2008). Mammalian xanthine oxidoreductase. Mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J. 275:3278–3289.
Okado-Matsumoto, A., and Fridovich, I. (2001). Subcellular distribution of superoxide dismutases (SOD) in rat liver -Cu,Zn-SOD- in mitochondria. J. Biol. Chem. 276:38388–38393.
Oliver, C. N., Ahn, B.W., Moerman, E. J., Goldstein, S., and Stadtman, E. R. (1987). Age-related changes in oxidized proteins. J. Biol. Chem. 262:5488–5491.
O’Loghlen, A., Perez-Morgado, M.I., Salinas, M. et al. (2003). Reversible inhibition of the protein phosphatase 1 by hydrogen peroxide. Potential regulation of eIF2 alpha phosphorylation in differentiated PC12 cells. Arch. Biochem. Biophys. 417:194–202.
Pearce, R.K., Owen, A., Daniel, S., et al. (1997). Alterations in the distribution of glutathione in the substantia nigra in Parkinson’s disease. J. Neural Transm. 104:661–677.
Praticò, D., and Sung, S. (2004). Lipid peroxidation and oxidative imbalance: early functional event in Alzheimer’s disease. J. Alzheimers Dis. 6:171–175.
Puddu, P., Puddu, G.M., Cravero, E., et al. (2008). The molecular sources of reactive oxygen species in hypertension. Blood Press.17:70–77.
Rahman, I., Gilmour, P.S., Jimenez, L.A. et al. (2002). Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol. Cell. Biochem. 234–235:239–248.
Rahman, I., Marwick, J., and Kirkham, P. (2004). Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem. Pharmacol. 68:1255–1267.
Rao, R.K., and Clayton, L.W. (2002). Regulation of protein phosphatase 2A by hydrogen peroxide and glutathionylation. Biochem. Biophys. Res. Commun. 293:610–616.
Refsgaard, H.H., Tsai, L., Stadtman, E.R. (2000). Modifications of proteins by polyunsaturated fatty acid peroxidation products. Proc. Natl. Acad. Sci. U.S.A. 97:611–616.
Royerpokora, B., Kunkel, L.M., Monaco, A.P., et al. (1986). Cloning the gene for an inherited human disorder -Chronic Granulomatous-Disease- on the basis of its chromosomal location. Nature 322:32–38.
Sadok, A., Bourgarel-Rey, V., Gattacceca, F., et al. (2008). Nox1-dependent superoxide production controls colon adenocarcinoma cell migration. Biochim. Biophys. Acta 1783:23–33.
Salh, B., Webb, K., Guyan, P.M., et al. (1989). Aberrant free radical activity in cystic fibrosis. Clin. Chim. Acta 181:65–74.
Salmeen, A., and Barford, D. (2005). Functions and mechanisms of redox regulation of cysteine-based phosphatases. Antioxid. Redox Signal. 7:560–577.
Savitsky, P.A., and Finkel, T. (2002). Redox regulation of Cdc25C. J. Biol. Chem. 277:20535–20540.
Schidlow, D.V. (2000). Newer therapies for cystic fibrosis. Paediatr. Respir. Rev. 1:107–113.
Shiose, A., Kuroda, J., Tsuruya, K., et al. (2001). A novel superoxide-producing NAD(P)H oxidase in kidney. J. Biol. Chem. 276:1417–1423.
Siew, E.L., Opalecky, D., and Bettelheim, F.A. (1981). Light scattering of normal human lens. II. Age dependence of the light scattering parameters. Exp. Eye Res. 33:603–614.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., et al. (1991). Excess brain protein oxidation and enzyme dysfunction in normal and Alzheimer’s disease. Proc. Natl. Acad. Sci. U.S.A. 88:10540–10543.
Spector, A. (1995). Oxidative stress-induced cataract: mechanism of action. FASEB J. 9:1173–1182.
Stadtman, E.R. (1990). Metal ion-catalyzed oxidation of proteins: biochemical mechanisms and biological consequences. Free Radical Biol. Med. 9:315–325.
Stadtman, E.R. (2001). Protein oxidation in aging and age-related diseases. Ann. New York Acad. Sci. 928:22–38.
Stadtman, E.R., and Berlett, B.S. (1997). Reactive oxygen-mediated protein oxidation in aging and disease. Chem. Res. Toxicol. 10:485–494.
Stadtman, E.R., and Levine, R.L. (2003). Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 25:207–218.
Starosta, V., Rietschel, E., Paul, K., et al. (2006). Oxidative changes of bronchoalveolar proteins in cystic fibrosis. Chest 129:431–437.
St-Pierre, J., Buckingham, J.A., Roebuck, S.J., et al. (2002). Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 277:44784–44790.
Suh, Y.A., Arnold, R.S., Lassegue, B., et al. (1999). Cell transformation by the superoxide-generating oxidase Mox1. Nature 401:79–82.
Suleyman, H., Demircan, B., and Karagoz, Y. (2007). Anti-inflammatory and side effects of cyclooxygenase inhibitors. Pharmacol. Rep. 59:247–258.
Sumimoto, H. (2008). Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J. 275:3249–3277.
Taira, T., Saito, Y., Niki, T., et al. (2004). DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 5:213–218.
Tanaka, T., Hosoi, F., Yamaguchi-Iwai, Y., et al. (2002). Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J. 21:1695–1703.
Thomas, B., and Beal, M.F. (2007). Parkinson’s disease. Human. Mol. Genet. 16:183–194.
Toledano, M.B., and Leonard, W.J. (1991). Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. U.S.A. 88:4328–4332.
Turrens, J.F., and Boveris, A. (1980). Generation of superoxide anion by the NADH dehydrogenase of bovine heart-mitochondria. Biochem. J. 191:421–427.
Turrens, J.F., Alexandre, A., and Lehninger, A.L. (1985). Ubisemiquinone is the electron-donor for superoxide formation by Complex III of heart-mitochondria. Arch. Biochem. Biophys. 237:408–414.
Vandermoere, F., El Yazidi-Belkoura, I., Adriaenssens, E., et al. (2005). The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-kappaB activation induced via interaction between Akt and IkappaB kinase-beta in breast cancer cells. Oncogene 24:5482–5491.
Vaquero, E.C., Edderkaoui, M., Pandol, S.J., et al. (2004). Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J. Biol. Chem. 279:34643–34654.
Vasquez-Vivar, J., Kalyanaraman, B., Martasek, P., et al. (1998). Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. U.S.A. 95:9220–9225.
West, S. (2007). Epidemiology of cataract: accomplishments over 25 years and future directions. Ophthalmic Epidemiol. 14:173–178.
Wientjes, F.B., Hsuan, J.J., Totty, N.F., et al. (1993). P40phox, a third cytosolic component of the activation complex of the NADP oxidase to contain Src homology 3 domains. Biochem. J. 296:557–561.
Williams, D.L. (2006). Oxidation, antioxidants and cataract formation: a literature review 1: Vet. Ophthalmol. 9:292–298.
Acknowledgments
This work was supported by Science Foundation Ireland, Children Leukemia Research Project and the Irish Cancer Society.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Quiney, C., Finnegan, S., Groeger, G., Cotter, T.G. (2011). Protein Oxidation. In: Vidal, C. (eds) Post-Translational Modifications in Health and Disease. Protein Reviews, vol 13. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6382-6_3
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6382-6_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6381-9
Online ISBN: 978-1-4419-6382-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)